ZZ-1003

N/A

Report date: 2023/05/22 10:16:42

Base Information

Drug NameZZ-1003
Drug Alias NameZZ-1003
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 6
Therapy Area/IndicationsSchizophreniaDepressionAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Zhongze Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Zhongze Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaDepressionAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A